In addition, IL-1β may increase neuronal excitability by down-modulating the astrocytic glutamate transporter (GLT-1) [60], which results in impaired glutamate clearance that has been identified as one of the causative factors in drug-resistant epilepsy [61]. The gene discussed is SLC1A2; the disease is epilepsy.